DH — Definitive Healthcare Corp.

Definitive Healthcare (DH) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: $61.5 million, down 1% year-over-year but above guidance.
• Subscription Revenue: $58.5 million, a 3% decline year-over-year.
• Professional Services Revenue: Strong performance with a 49% increase year-over-year.
• Adjusted EBITDA: $18.1 million, representing a 29% margin, exceeding guidance by $1.1 million.
• Unlevered Free Cash Flow: Approximately $55 million for the trailing 12 months.
• Full Year 2025 Revenue: $241.5 million, a 4% decline year-over-year.
• Gross Dollar Retention: Improved by 2 points year-over-year, while net dollar retention declined due to reduced upsell opportunities.

2. Strategic Updates and Business Highlights

• Operational Progress: Focused on four strategic pillars: data differentiation, seamless integrations, customer success, and innovation.
• Data Differentiation: Successfully restored claims data volumes and improved data quality, including the addition of mobile phone data for healthcare executives.
• Integrations: Increased the number of integrations with platforms like Snowflake and HubSpot, enhancing customer satisfaction and retention.
• Customer Success Initiatives: Improved retention rates through enhanced customer engagement processes and proactive risk management.
• Innovation: Launched a new claims data source and expanded digital engagement initiatives, including partnerships with agencies and AI integration into products.

3. Forward Guidance and Outlook

• Q1 2026 Revenue Guidance: Expected between $54 million and $56 million, reflecting a 5% to 9% year-over-year decline.
• Full Year 2026 Revenue Guidance: Anticipated between $220 million and $226 million, a 6% to 9% decline year-over-year.
• Adjusted EBITDA for 2026: Expected between $53 million and $58 million, with a margin of 24% to 26%.
• NDR Improvement: Expected modest improvement in net dollar retention in 2026, with a focus on restoring upsell opportunities.

4. Bad News, Challenges, or Points of Concern

• Revenue Decline: Continued pressure on revenue, particularly in subscription services, with a noted decline in net dollar retention.
• Claims Data Disruption: Previous disruptions in claims data have negatively impacted customer satisfaction and upsell opportunities.
• Customer Count: Anticipated declines in customer count, which may affect revenue per customer.
• Macroeconomic Environment: Ongoing challenges in the broader economic landscape that could impact future performance.

5. Notable Q&A Insights

• Demand Environment: No significant changes in demand across end markets, but some positive signs of sales cycle condensing.
• Life Sciences Market: Despite upsell pressures, gross dollar retention improved, particularly among enterprise customers.
• AI Impact: AI is seen as a competitive advantage, enhancing existing workflows rather than detracting from traditional vendor budgets.
• Renewal Dynamics: The timing of product updates may not have significantly influenced Q4 renewals, but improvements are expected in early 2026.
• Go-to-Market Strategy: Plans to refine sales motions to drive better upsells alongside product innovations.

Overall, while Definitive Healthcare has made strides in operational improvements and strategic initiatives, it faces ongoing revenue pressures and challenges in customer retention that will need to be addressed in 2026.